ProKidney Corp. (PROK)
1.83
-0.02
(-1.08%)
USD |
NASDAQ |
Sep 10, 16:00
1.83
0.00 (0.00%)
After-Hours: 20:00
ProKidney Net Income (Quarterly) : -46.44M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -46.44M |
| March 31, 2026 | -42.62M |
| December 31, 2025 | -40.85M |
| September 30, 2025 | -35.84M |
| June 30, 2025 | -36.96M |
| March 31, 2025 | -37.95M |
| December 31, 2024 | -48.48M |
| September 30, 2024 | -41.05M |
| June 30, 2024 | -38.47M |
| March 31, 2024 | -35.33M |
| December 31, 2023 | -21.72M |
| Date | Value |
|---|---|
| September 30, 2023 | -41.99M |
| June 30, 2023 | -34.82M |
| March 31, 2023 | -36.91M |
| December 31, 2022 | -24.57M |
| September 30, 2022 | -33.94M |
| June 30, 2022 | -22.13M |
| March 31, 2022 | -67.49M |
| December 31, 2021 | -13.67M |
| September 30, 2021 | -17.14M |
| June 30, 2021 | -0.0001M |
| March 31, 2021 | -0.0052M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.15M |
| Total Expenses (Quarterly) | 28.57M |
| EPS Diluted (Quarterly) | -0.1524 |
| Enterprise Value | 1.309B |
| Gross Profit Margin (Quarterly) | -866.0% |
| Profit Margin (Quarterly) | -30.96K% |
| Earnings Yield | -30.19% |
| Normalized Earnings Yield | -30.19 |